Patents by Inventor Simone CUMMINGS

Simone CUMMINGS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11841366
    Abstract: The invention relates generally to immunoassays, and more particularly to monoclonal antibodies and immunoassays for the differential detection and quantitation of a wild-type crystal protein, such as a wild-type-Cry1Ab, from Bacillus thuringiensis and hybrid crystal proteins, which comprise all or a significant portion of the wild-type Cry protein in complex biological samples comprising both the wild-type Cry protein and one or more of the hybrid Cry proteins.
    Type: Grant
    Filed: March 17, 2020
    Date of Patent: December 12, 2023
    Assignee: Syngenta Participations AG
    Inventors: Simone Cummings, Julie Smith, Magda Foege
  • Publication number: 20210293807
    Abstract: The invention relates generally to immunoassays, and more particularly to monoclonal antibodies and immunoassays for the differential detection and quantitation of a wild-type crystal protein, such as a wild-type-Cry1Ab, from Bacillus thuringiensis and hybrid crystal proteins, which comprise all or a significant portion of the wild-type Cry protein in complex biological samples comprising both the wild-type Cry protein and one or more of the hybrid Cry proteins.
    Type: Application
    Filed: March 17, 2020
    Publication date: September 23, 2021
    Applicant: Syngenta Participations AG
    Inventors: Simone CUMMINGS, Julie SMITH, Magda FOEGE
  • Patent number: 10634675
    Abstract: The invention relates generally to immunoassays, and more particularly to monoclonal antibodies and immunoassays for the differential detection and quantitation of a wild-type crystal protein, such as a wild-type-Cry1Ab, from Bacillus thuringiensis and hybrid crystal proteins, which comprise all or a significant portion of the wild-type Cry protein in complex biological samples comprising both the wild-type Cry protein and one or more of the hybrid Cry proteins.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: April 28, 2020
    Assignee: Syngenta Participations AG
    Inventors: Simone Cummings, Julie Smith, Magda Foege
  • Publication number: 20180313833
    Abstract: The invention relates generally to immunoassays, and more particularly to monoclonal antibodies and immunoassays for the differential detection and quantitation of a wild-type crystal protein, such as a wild-type-Cry1Ab, from Bacillus thuringiensis and hybrid crystal proteins, which comprise all or a significant portion of the wild-type Cry protein in complex biological samples comprising both the wild-type Cry protein and one or more of the hybrid Cry proteins.
    Type: Application
    Filed: August 25, 2016
    Publication date: November 1, 2018
    Applicant: Syngenta Participations AG
    Inventors: Simone CUMMINGS, Julie SMITH, Magda FOEGE